-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903. Health Services Research—Malignant Conditions (Myeloid Disease): Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, Biological, Coronaviruses, Leukemia, multiple myeloma, SARS-CoV-2/COVID-19, therapy sequence, CML, Diseases, Lymphoma (any), Non-Biological, Bone Marrow Failure, Combinations, Elderly, Therapies, chemotherapy, Non-Hodgkin Lymphoma, Biological Processes, DLBCL, MPN, Polycythemia vera, Technology and Procedures, immunotherapy, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Clinically relevant, genomics, Myeloid Malignancies, Quality Improvement , TKI, molecular testing, NGS
Monday, December 7, 2020: 7:00 AM-3:30 PM

Ashley Tabah1*, David Huggar1*, Si-Tien Wang2*, Scott J. Johnson2*, Ronda Copher, PhD1*, Thomas O'Connell2* and Thomas W. Leblanc3

1Bristol Myers Squibb, Princeton, NJ
2Medicus Economics, Boston, MA
3Duke Cancer Institute, Durham, NC

Meletios A. Dimopoulos, MD1, Frank Campana, MD2*, Denise Bury, MPH, PhD2*, Sophie Guillonneau3*, Cheng Zheng2*, Peggy Lin, PhD2*, Paul G. Richardson, MD4 and Michel Delforge, MD PhD5

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Sanofi Genzyme, Cambridge, MA
3Sanofi Genzyme, Chilly-Mazarin, France
4Dana-Farber Cancer Institute, Boston, MA
5Department of Hematology, University Hospital Leuven, Leuven, Belgium

Savanah D. Gisriel, MD, MPH1*, Henry M. Rinder, MD2 and Alexa J. Siddon, MD3

1Department of Pathology, Yale School of Medicine, Hamden, CT
2Departments of Laboratory Medicine & Medicine (Hematology), Yale School of Medicine, New Haven, CT
3Departments of Laboratory Medicine and Pathology, Yale School of Medicine, New Haven, CT

Stephanie J. Yaung, PhD1*, Adeline Pek, MS1*, Lili Niu, PhD2*, Jian Li, PhD2*, John F. Palma, PhD1* and Maximilian Schmid, MD1*

1Roche Sequencing Solutions, Inc., Pleasanton, CA
2Roche Sequencing Solutions, Inc., Belmont, CA

Kimberly C Jenkins, MSNM1*, Emily C Zabor, DrPH2*, Lindsey A. R. Mooney, BS1*, Aaron T. Gerds, MD, MS3, Kerry O'Hop, BS4*, Makenzie Guy, BA4*, Megan Kilbane, MBA1*, Nathan A Pennell, MD, PhD4* and Mikkael A. Sekeres, MD, MS5

1Hematology and Medical Oncology Research, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
2Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
3Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Lung Program, Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
5Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Jonathan K. Kish, PhD, MPH1*, Arianna Kee2*, Pranav Abraham2*, Ronda Copher, PhD2*, Talia Miller1* and Aaron T. Gerds, MD, MS3

1Cardinal Health, Dublin, OH
2Bristol Myers Squibb, Princeton, NJ
3Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Rory M. Shallis, MD1, Rong Wang, PhD2*, Jan Philipp Bewersdorf, MD3*, Amer M. Zeidan, MBBS, MHS4, Scott F. Huntington, MD, MPH5, Amy J Davidoff, PhD, MS6*, Xiaomei Ma, PhD7* and Nikolai A. Podoltsev, MD, PhD8

1Yale Cancer Center, West Haven, CT
2Yale University School of Public Health, New Haven, CT
3Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
4Yale University School of Medicine and Yale Cancer Center, New Haven, CT
5Hematology, Yale University School of Medicine, New Haven, CT
6Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT
7Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT
8Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Madison, CT

Ashley Tabah1*, David Huggar1*, Krystal Huey1*, Ronda Copher, PhD1*, Zheng-Yi Zhou2*, Miriam L. Zichlin3*, Sarah H. Koenigsberg2* and Andrew M. Brunner4*

1Bristol Myers Squibb, Princeton, NJ
2Analysis Group Inc., Boston, MA
3Analysis Group, Inc., Boston, MA
4Massachusetts General Hospital, Boston, MA

Anthony Vito Pasquarella, MD1, Angela Ramdhanny, MD2*, Mina Gendy, DO1*, Priya Pinto, MD3*, Shahidul Islam, DrPH, MPH, PStat4* and Marc Braunstein, MD, PhD5

1Division of Hematology/Oncology, NYU Long Island School of Medicine, Mineola, NY
2Department of Internal Medicine, NYU Winthrop Hospital, Mineola, NY
3Division of Palliative Care, NYU Long Island School of Medicine, Mineola, NY
4Department of Biostatistics, NYU Long Island School of Medicine, Mineola, NY
5Division of Oncology-Hematology, NYU Long Island School of Medicine, NYU Winthrop Hospital, NYU Langone Health, Great Neck, NY

Eri Kawata, MD, PhD1,2,3, Anargyros Xenocostas, MD, FRCPC4,5, Cyrus C. Hsia, MD, BSc, FRCPC4,5,6, Alejandro Lazo-Langner, MD, MSc4,5, Michael Levy, PhD7*, Stephanie Santos7*, Hanxin Lin, PhD6,7*, Chris Howlett6,7*, Bekim Sadikovic, PhD, DABMGG, FACMG6,7* and Ian Chin-Yee, MD, FRCPC4,5,6

1Division of Hematology, Department of Medicine, London Health Sciences Centre, Kyoto-Shi, KYO, Japan
2Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
3Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan
4Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
5Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada
6Department of Pathology & Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
7Molecular Genetics Laboratory, London Health Sciences Centre, London, ON, Canada

*signifies non-member of ASH